Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Investigation of biomarkers to predict outcomes in allogeneic hematopoietic stem cell transplantation.
Tachibana T, Miyazaki T, Matsumura A, Hagihara M, Tanaka M, Koyama S, Ogusa E, Aoki J, Nakajima Y, Takahashi H, Suzuki T, Ishii Y, Teshigawara H, Matsumoto K, Hatayama M, Izumi A, Ikuta K, Yamamoto K, Kanamori H, Fujisawa S, Nakajima H. Tachibana T, et al. Among authors: ogusa e. Cytotherapy. 2024 Mar 30:S1465-3249(24)00575-9. doi: 10.1016/j.jcyt.2024.03.490. Online ahead of print. Cytotherapy. 2024. PMID: 38625069
Computed tomography-defined sarcopenia: prognostic predictor of nonrelapse mortality after allogeneic hematopoietic stem cell transplantation: a multicenter retrospective study.
Ando T, Fujisawa S, Teshigawara H, Matsumura A, Sakuma T, Suzuki T, Teranaka H, Ogusa E, Ishii Y, Miyashita K, Takahashi H, Nakajima Y, Miyazaki T, Hagihara M, Matsumoto K, Yamazaki E, Nakajima H. Ando T, et al. Among authors: ogusa e. Int J Hematol. 2020 Jul;112(1):46-56. doi: 10.1007/s12185-020-02870-5. Epub 2020 May 25. Int J Hematol. 2020. PMID: 32451786
Impact of treatment-related weight changes from diagnosis to hematopoietic stem-cell transplantation on clinical outcome of acute myeloid leukemia.
Ando T, Fujisawa S, Teshigawara H, Ogusa E, Ishii Y, Miyashita K, Motohashi K, Miyazaki T, Tachibana T, Hagihara M, Matsumoto K, Tanaka M, Hashimoto C, Koharazawa H, Fujimaki K, Taguchi J, Fujita H, Kanamori H, Yamazaki E, Nakajima H; Yokohama Cooperative Study Group for Hematology (YACHT). Ando T, et al. Among authors: ogusa e. Int J Hematol. 2019 Jun;109(6):673-683. doi: 10.1007/s12185-019-02647-5. Epub 2019 Apr 8. Int J Hematol. 2019. PMID: 30963469
Clinical Significance of Serum Ferritin at Diagnosis in Patients With Acute Myeloid Leukemia: A YACHT Multicenter Retrospective Study.
Tachibana T, Andou T, Tanaka M, Ito S, Miyazaki T, Ishii Y, Ogusa E, Koharazawa H, Takahashi H, Motohashi K, Aoki J, Nakajima Y, Matsumoto K, Hagihara M, Hashimoto C, Taguchi J, Fujimaki K, Fujita H, Fujisawa S, Kanamori H, Nakajima H; Yokohama Cooperative Study Group for Hematology (YACHT). Tachibana T, et al. Among authors: ogusa e. Clin Lymphoma Myeloma Leuk. 2018 Jun;18(6):415-421. doi: 10.1016/j.clml.2018.03.009. Epub 2018 Mar 31. Clin Lymphoma Myeloma Leuk. 2018. PMID: 29673622
Peripheral Blood Monocyte Count is a Predictor of Successful Peripheral Blood Stem Cell Harvest After Chemo-Mobilization in Patients with Malignant Lymphoma.
Ishii Y, Fujisawa S, Nigauri C, Ando T, Suzuki T, Ogusa E, Miyashita K, Motohashi K, Nakajima H. Ishii Y, et al. Among authors: ogusa e. Indian J Hematol Blood Transfus. 2018 Apr;34(2):347-349. doi: 10.1007/s12288-017-0848-2. Epub 2017 Jul 7. Indian J Hematol Blood Transfus. 2018. PMID: 29622882 Free PMC article. No abstract available.
Body mass index is a prognostic factor in adult patients with acute myeloid leukemia.
Ando T, Yamazaki E, Ogusa E, Ishii Y, Yamamoto W, Motohashi K, Tachibana T, Hagihara M, Matsumoto K, Tanaka M, Hashimoto C, Koharazawa H, Fujimaki K, Taguchi J, Fujita H, Kanamori H, Fujisawa S, Nakajima H; Yokohama Cooperative Study Group for Hematology (YACHT). Ando T, et al. Among authors: ogusa e. Int J Hematol. 2017 May;105(5):623-630. doi: 10.1007/s12185-017-2183-7. Epub 2017 Jan 21. Int J Hematol. 2017. PMID: 28110409
Outcome and prognostic factors among patients who underwent a second transplantation for disease relapse post the first allogeneic cell transplantation.
Tachibana T, Matsumoto K, Tanaka M, Hagihara M, Motohashi K, Yamamoto W, Ogusa E, Koyama S, Numata A, Tomita N, Taguchi J, Fujisawa S, Kanamori H, Nakajima H. Tachibana T, et al. Among authors: ogusa e. Leuk Lymphoma. 2017 Jun;58(6):1403-1411. doi: 10.1080/10428194.2016.1243678. Epub 2016 Oct 14. Leuk Lymphoma. 2017. PMID: 27739916
Hyper-recovery of platelets after induction therapy is a predictor of relapse-free survival in acute myeloid leukemia.
Yamazaki E, Kanamori H, Itabashi M, Ogusa E, Numata A, Yamamoto W, Ito S, Tachibana T, Hagihara M, Matsumoto K, Koharazawa H, Taguchi J, Tomita N, Fujimaki K, Fujita H, Fujisawa S, Ogawa K, Ishigatsubo Y. Yamazaki E, et al. Among authors: ogusa e. Leuk Lymphoma. 2017 Jan;58(1):104-109. doi: 10.1080/10428194.2016.1190969. Epub 2016 Jun 7. Leuk Lymphoma. 2017. PMID: 27267543
24 results